HP-hMG
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HP-hMG, covering 2011-04-07 to 2017-05-31. Get the full timeline:
Most recent: Clinical Trial Update: Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.